cordenpharma.comCrawled Oct 16, 2026
The page discusses aseptic fill and finish sterile injectable manufacturing capacity expansions from clinical to commercial scale.
CordenPharma's integrated facility network across Europe and the US provide flexible contract manufacturing of APIs & Drug Producs with GMP compliance.
CordenPharma CDMO provides integrated supply of APIs, Drug Products, Lipids & LNPs for the development & manufacture of complex modalities at all stages.
CordenPharma's Project Management team ensures aligned API, Drug Product & Lipid process development, analytical, quality and compliance expertise.
Chemistry is a high-tech science. CordenPharma Chenôves attracts pharma talent who love science and want to industrialize it.
Press Release 10-1-2023: CordenPharma signs multi-year agreement for the contract manufacturing of a large-volume commercial peptide.
CordenPharma provides peptide API CDMO supply from small scale through FIH clinical development and commercialization, using SPPS and TAPs.
CordenPharma offers small molecule drug substance and drug product capabilities.
CordenPharma's 20th anniversary is in 2026.
CordenPharma LNP Summit - Sept 9 2025: experts discussed extra-hepatic & targeted nanoparticle Drug Delivery & CDMO LNP Formulation scale-up.
CordenPharma's events page covers pharmaceutical trade show exhibits, including CPHI, and sponsored presentations by CordenPharma scientists.
The page covers CordenPharma's latest news, events, and resources.
CordenPharma offers pharmaceutical roles and describes its work environment as fostering diversity, inclusion, and personal career development.
CordenPharma has openings for engineers, operators, and supply chain managers for pharmaceutical CDMO jobs near Basel, Switzerland.
CordenPharma has openings for engineers, operators, and supply chain managers for peptide pharmaceutical jobs in Boulder, Colorado.
CordenPharma has pharmaceutical job and career opportunities.
The page presents CordenPharma's Executive Leadership team, whose members have extensive pharmaceutical industry experience.
CordenPharma Technology & Scientific Advisory Board consists of: Dr. Chantal Pichon, Dr. Olivia Merkel, Dr. Jean-Christophe M. Monbaliu,, Dr. Roderich D. Süssmuth & Dr. Karl Wagner.
CordenPharma is a full-service CDMO for the global market, providing expert support for the development and manufacturing of APIs, Excipients, Drug Products, and associated Packaging Services.
CordenPharma culture is built on values of integrity, accountability, trust, collaboration & reliability with a focus on diversity, career growth & ESG.
CordenPharma's mission & vision is to support global Pharmaceutical & Biotechnology customers with high-quality products for the well-being of patients.
CordenPharma's quality management systems ensure compliance at its global cGMP facilities and support patient safety.
CordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.
CordenPharma South Carolina marks the groundbreaking of a major expansion for U.S. peptide manufacturing, with South Carolina Governor Henry McMaster joining the celebration. The expansion represents a $200 million investment to advance peptide manufacturing in the United States. The groundbreaking celebration takes place on September 22, 2026.
Sep 2026 · CordenPharmaNews article
CordenPharma appoints Dr. Jean-Luc Herbeaux as chief executive officer, effective October 1, 2026. Dr. Michael Quirmbach transitions from CEO to board member and senior advisor.
Sep 2026 · CordenPharmaNews article
CordenPharma is increasing its sterile injectable manufacturing capacity to 500 million units per year. The CDMO says a multi-year investment of €80 million will fund a new facility and additional aseptic fill-and-finish lines.
Sep 2026 · CordenPharmaNews article
CordenPharma completes its acquisition of peptide CDMO AmbioPharm. AmbioPharm has sites in South Carolina, United States, and Shanghai, China.
Aug 2026 · CordenPharmaNews article
